The FDA has dashed Sanofi’s hopes of launching its type I diabetes drug, Zynquista, this year.
News
Nearly half of British public regret not pursuing science-based career
A new study has claimed that Britain is a nation of would-be scientists who regret their career choices.
Cardiff Uni launches Medicines Discovery Institute
Cardiff University is launching a new Medicines Discovery Institute.
Venclexta safety warnings in multiple myeloma patients
US regulators have posted a safety statement warning of an increased risk of death for patients receiving AbbVie’s venetoclax with bortezomib and dexamethasone for melanoma patients.
Alzheimer’s trial discontinued due to inefficiency
Two global Phase III trials of the Alzheimer’s drug aducanumab have been discontinued, after the drug failed to hit efficacy targets.
Multi-drug approach found to attack resistance in bowel cancer
A new study has shown that triple drug combinations could prevent resistance in many cancer types.
Long-term data shows promise in breast cancer biosimilar
The a three-year follow-up study comparing Ontruzant to Herceptin has found the biosimilar to be just as successful.
£23 million funding for cutting edge health projects
£23 million of government funding has been awarded to cutting edge health projects.
Researchers to test heart drug for COPD patients
University of Aberdeen researchers are set to test beta-blockers for COPD patients.
NICE nod for Takeda’s Adcetris in advanced stage CTCL
Takeda has announced the NICE recommendation of Adcetris for advanced cutaneous T-cell lymphoma.
Celgene and Exscientia ink three year AI drug discovery collaboration
Exscientia has announced a three-year drug discovery AI collaboration with Celgene.
CCG report shows increase in emergency readmissions
NHS Digital has published emergency readmissions statistics for first time in five years.
EU gives Uni of St Andrews 4.37m Euros for medical data study
The European Union has announced it is to give The University of St Andrews 4.37 million Euros for a medical data study.
Pfizer buys stake in French gene therapy company Vivet
Pfizer has announced a collaboration with Vivet on the development of a potential breakthrough therapy for Wilson disease.
Biotech growth in UK booms 65% since 2016
The number of active UK biotechnology businesses in the R&D field has soared by 65% in just over three years.
